TUG1 and cancer: In this study, the establishment of a xenograft tumor model in nude mice using paclitaxel resistant A2780 cells with or without TUG1 silencing, confirmed that TUG1 promoted cancer progression and paclitaxel resistance in vivo by inhibiting miR-29b-3p [99].